EMA Authorised: Bortezomib Sun (bortezomib) — SUN Pharmaceutical Industries (Europe) B.V.

View source ↗

Summary

The European Medicines Agency authorised Bortezomib Sun by SUN Pharmaceutical Industries (Europe) B.V. for use in multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib Sun (bortezomib)

Snippet

Status: Authorised. Therapeutic area: Multiple Myeloma. MAH: SUN Pharmaceutical Industries (Europe) B.V.. Decision date: 10/10/2025